Health ❯ Healthcare

Regulatory Agencies

FDA MHRA Anvisa European Medicines Agency Drug Approval Process ANSM Food and Drug Administration Drug Safety ANMAT Drug Approval

Reports Say Trump Approved Plan to Remove FDA Chief Marty Makary as Questions Mount

The standoff underscores concerns about political pressure on FDA decisions that shape public health.

Reports Say Trump Signs Off on Plan to Remove FDA Chief Marty Makary

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

FDA Elevates Nationwide Cough-Drop Recall to Class II

Australia Begins Permanently Listing Health Practitioners’ Sexual Misconduct on Public Register

Brazil Cracks Down on Illegal GLP-1 Weight‑Loss Injections as Anvisa Tightens Oversight

FDA Flags Recall of 3.1 Million Store-Brand Eye Drops Over Sterility Concerns

3.1 Million Bottles of Store-Brand Eye Drops Recalled for Sterility Concerns

Fiocruz Flags Rising Influenza A and Severe Respiratory Cases Across Brazil

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

Mexico Launches IMPI–COFEPRIS Portal for Real-Time Health Patent Data

UK Regulator Recalls 50,000 Hibiwash Bottles Over Bacterial Contamination Risk

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

Anvisa Issues Safety Alert on Misuse of Dermal Fillers in Brazil

UKHSA Renews Warning on Four Wet Wipe Brands Linked to Burkholderia Outbreak

Tesco Recalls Ramipril 5mg Batch Over Packaging Mix‑Up With 'Do Not Use' Warning

UK Orders Class 2 Recall of Ramipril Batch After Amlodipine Found in Packs

FOI Reveals Two Suspected GLP‑1 Drug Deaths in Northern Ireland